Alaska Native Communities Advancing Vaccine Uptake

阿拉斯加原住民社区促进疫苗接种

基本信息

  • 批准号:
    10504537
  • 负责人:
  • 金额:
    $ 70.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-08-18 至 2027-07-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Alaska Native and American Indian (ANAI) communities are experiencing a disproportionate share of SARS- CoV-2 infection and its sequelae in the US. As of September 2021, ANAI people had a cumulative incidence of 9,256 COVID-19 cases per 100,000, compared with 5,445 among non-Hispanic Whites. The current rate of COVID-19 associated deaths per 100,000 population is 220 among ANAI people, compared with 137 among non-Hispanic Whites. Widespread vaccination remains the best strategy to control COVID-19 morbidity and mortality, but the US has one of the lowest vaccine acceptance rates in the world with wide regional variability. Little research has attempted to understand or address barriers to COVID-19 vaccination in ANAI people, despite unique geographical, historical, and cultural factors that could influence vaccine uptake in this population. We have formed a consortium of Tribal health leaders from across Alaska to better understand vaccine attitudes and intentions, including hesitancy, and to increase vaccine uptake in Alaskan ANAI communities. In conjunction with community advisors, we will develop and implement a theory-driven intervention that is grounded in ANAI values of relationality and respect. First, we will use vaccination tracking data to assess current rates of vaccine uptake and analyze preexisting quantitative and qualitative data regarding vaccine attitudes, intentions, and behavior among ANAI people in rural and urban areas of Alaska. We will also conduct a survey in southcentral Alaska to inform intervention design. Second, we will work with statewide Tribal health leaders and regional Community Advisory Boards to create educational information, stories, and messages keyed to the beliefs and perceived norms that drive vaccine behavior. This content will be incorporated into an eHealth toolkit for use by community members and specially trained community vaccine advocates, laypeople who volunteer to provide information and motivational/emotional support to their friends, families, and communities. Third, we will launch the intervention in the southcentral region of Alaska and evaluate effectiveness using the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE- AIM) framework. Refinements based on program data and participant feedback will be made, then the refined intervention will be deployed in two rural regions of Alaska and evaluated. This project will add to the limited evidence base regarding adult vaccine attitudes, intentions, and behaviors among ANAI people. It holds the potential to increase vaccination in a hard-hit population and build support for future vaccination as SARS-CoV2 continues to evolve. Our findings will have broader applicability to vaccine outreach and engaging ANAI communities in leveraging peer relationships, their social networks, and eHealth to promote health education and behavior change.
项目摘要 阿拉斯加原住民和美洲印第安人(ANAI)社区正在经历不成比例的SARS- 美国的CoV-2感染及其后遗症。截至2021年9月,ANAI人群累计发病率为 每10万人中有9,256例COVID-19病例,而非西班牙裔白人为5,445例。从现时的 在ANAI人群中,每10万人口中COVID-19相关死亡人数为220人,而在 非西班牙裔白人广泛接种疫苗仍然是控制COVID-19发病率的最佳策略, 死亡率,但美国是世界上疫苗接受率最低的国家之一,具有广泛的区域差异。 很少有研究试图了解或解决ANAI人群接种COVID-19疫苗的障碍, 尽管独特的地理,历史和文化因素可能影响疫苗的吸收, 人口我们成立了一个由阿拉斯加各地部落健康领导人组成的联盟, 疫苗态度和意向,包括犹豫,并增加阿拉斯加ANAI的疫苗接种率 社区.与社区顾问一起,我们将开发和实施一个理论驱动的 干预是基于ANAI的关系和尊重的价值观。首先,我们将使用疫苗接种跟踪 评估当前疫苗接种率并分析现有定量和定性数据的数据 关于阿拉斯加农村和城市地区ANAI人的疫苗态度,意图和行为。 我们还将在阿拉斯加中南部进行一项调查,为干预设计提供信息。第二,我们将与 全州部落卫生领导人和区域社区咨询委员会创建教育信息, 故事,以及与驱动疫苗行为的信念和感知规范相关的信息。此内容将 纳入电子健康工具包,供社区成员和受过专门培训的社区使用 疫苗倡导者,自愿为他们提供信息和动机/情感支持的非专业人士, 朋友、家人和社区。第三,我们将在阿拉斯加中南部地区展开干预行动 并使用覆盖、有效性、采用、实施和维护(RE- AIM)框架。将根据项目数据和参与者反馈进行改进,然后改进 将在阿拉斯加的两个农村地区部署干预措施并进行评估。该项目将增加有限的 关于成人疫苗的态度,意向和行为的证据库。它持有的 有可能在受影响严重的人群中增加疫苗接种,并为未来的疫苗接种提供支持, SARS-CoV 2继续发展。我们的发现将对疫苗推广具有更广泛的适用性, 让ANAI社区参与利用同伴关系、他们的社交网络和电子健康来促进 健康教育和行为改变。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ann D Collier其他文献

Ann D Collier的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ann D Collier', 18)}}的其他基金

Building Capacity for Dissemination and Implementation Research in a Tribal Healthcare System
部落医疗保健系统传播和实施研究的能力建设
  • 批准号:
    10494079
  • 财政年份:
    2021
  • 资助金额:
    $ 70.88万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 70.88万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.88万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 70.88万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.88万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 70.88万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 70.88万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.88万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 70.88万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 70.88万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 70.88万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了